nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—Paget's disease of bone—sarcoma	0.866	1	CtDrD
Alendronate—FDPS—periosteum—sarcoma	0.00568	0.0843	CbGeAlD
Alendronate—PTPRE—mammary gland—sarcoma	0.00476	0.0708	CbGeAlD
Alendronate—PTPRE—hematopoietic system—sarcoma	0.0029	0.0431	CbGeAlD
Alendronate—PTPN4—hematopoietic system—sarcoma	0.00276	0.041	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—MITF—sarcoma	0.00245	0.347	CbGpPWpGaD
Alendronate—PTPRS—connective tissue—sarcoma	0.00228	0.0338	CbGeAlD
Alendronate—ATP6V1A—mammary gland—sarcoma	0.00224	0.0333	CbGeAlD
Alendronate—PTPRE—cardiac atrium—sarcoma	0.0022	0.0327	CbGeAlD
Alendronate—PTPN4—uterus—sarcoma	0.00209	0.031	CbGeAlD
Alendronate—PTPRE—bone marrow—sarcoma	0.00186	0.0276	CbGeAlD
Alendronate—PTPN4—tendon—sarcoma	0.00183	0.0271	CbGeAlD
Alendronate—PTPN4—bone marrow—sarcoma	0.00177	0.0263	CbGeAlD
Alendronate—PTPRE—testis—sarcoma	0.00159	0.0236	CbGeAlD
Alendronate—ATP6V1A—myometrium—sarcoma	0.00159	0.0236	CbGeAlD
Alendronate—ATP6V1A—embryo—sarcoma	0.00153	0.0227	CbGeAlD
Alendronate—PTPRS—bone marrow—sarcoma	0.00152	0.0225	CbGeAlD
Alendronate—PTPN4—testis—sarcoma	0.00151	0.0225	CbGeAlD
Alendronate—PTPRE—liver—sarcoma	0.0015	0.0223	CbGeAlD
Alendronate—PTPN4—liver—sarcoma	0.00143	0.0212	CbGeAlD
Alendronate—ATP6V1A—hematopoietic system—sarcoma	0.00136	0.0203	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—FOXO1—sarcoma	0.00132	0.187	CbGpPWpGaD
Alendronate—PTPRS—testis—sarcoma	0.0013	0.0193	CbGeAlD
Alendronate—PTPRS—liver—sarcoma	0.00123	0.0182	CbGeAlD
Alendronate—FDPS—myometrium—sarcoma	0.0012	0.0178	CbGeAlD
Alendronate—ATP6V1A—skin of body—sarcoma	0.00119	0.0176	CbGeAlD
Alendronate—PTPRE—lymph node—sarcoma	0.00115	0.0171	CbGeAlD
Alendronate—PTPN4—lymph node—sarcoma	0.0011	0.0163	CbGeAlD
Alendronate—FDPS—seminal vesicle—sarcoma	0.00108	0.0161	CbGeAlD
Alendronate—ATP6V1A—cardiac atrium—sarcoma	0.00104	0.0154	CbGeAlD
Alendronate—ATP6V1A—uterus—sarcoma	0.00103	0.0153	CbGeAlD
Alendronate—FDPS—hematopoietic system—sarcoma	0.00103	0.0153	CbGeAlD
Alendronate—FDPS—connective tissue—sarcoma	0.00099	0.0147	CbGeAlD
Alendronate—ATP6V1A—lymphoid tissue—sarcoma	0.000961	0.0143	CbGeAlD
Alendronate—PTPRS—lymph node—sarcoma	0.00094	0.014	CbGeAlD
Alendronate—FDPS—smooth muscle tissue—sarcoma	0.000905	0.0134	CbGeAlD
Alendronate—ATP6V1A—tendon—sarcoma	0.000903	0.0134	CbGeAlD
Alendronate—FDPS—skin of body—sarcoma	0.000894	0.0133	CbGeAlD
Alendronate—ATP6V1A—bone marrow—sarcoma	0.000875	0.013	CbGeAlD
Alendronate—FDPS—cardiac atrium—sarcoma	0.00078	0.0116	CbGeAlD
Alendronate—FDPS—uterus—sarcoma	0.000776	0.0115	CbGeAlD
Alendronate—ATP6V1A—testis—sarcoma	0.000748	0.0111	CbGeAlD
Alendronate—FDPS—lymphoid tissue—sarcoma	0.000724	0.0107	CbGeAlD
Alendronate—ATP6V1A—liver—sarcoma	0.000707	0.0105	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—JUN—sarcoma	0.00069	0.0977	CbGpPWpGaD
Alendronate—FDPS—tendon—sarcoma	0.00068	0.0101	CbGeAlD
Alendronate—FDPS—bone marrow—sarcoma	0.000659	0.00979	CbGeAlD
Alendronate—FDPS—testis—sarcoma	0.000563	0.00837	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—MYC—sarcoma	0.000555	0.0785	CbGpPWpGaD
Alendronate—ATP6V1A—lymph node—sarcoma	0.000542	0.00805	CbGeAlD
Alendronate—FDPS—liver—sarcoma	0.000533	0.00791	CbGeAlD
Alendronate—Ulcer—Etoposide—sarcoma	0.000498	0.00835	CcSEcCtD
Alendronate—Lymphopenia—Doxorubicin—sarcoma	0.000477	0.00801	CcSEcCtD
Alendronate—Gastric ulcer—Epirubicin—sarcoma	0.000454	0.00762	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—COL18A1—sarcoma	0.000452	0.064	CbGpPWpGaD
Alendronate—Transaminases increased—Epirubicin—sarcoma	0.000434	0.00728	CcSEcCtD
Alendronate—Oesophagitis—Etoposide—sarcoma	0.00043	0.00722	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.000425	0.00714	CcSEcCtD
Alendronate—Gastric ulcer—Doxorubicin—sarcoma	0.00042	0.00705	CcSEcCtD
Alendronate—FDPS—lymph node—sarcoma	0.000408	0.00606	CbGeAlD
Alendronate—Dysphagia—Dactinomycin—sarcoma	0.000408	0.00685	CcSEcCtD
Alendronate—Transaminases increased—Doxorubicin—sarcoma	0.000401	0.00674	CcSEcCtD
Alendronate—Hypercalcaemia—Epirubicin—sarcoma	0.00038	0.00638	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.000361	0.00605	CcSEcCtD
Alendronate—Stomatitis—Thiotepa—sarcoma	0.000357	0.006	CcSEcCtD
Alendronate—Stomatitis—Dactinomycin—sarcoma	0.000355	0.00595	CcSEcCtD
Alendronate—Hypercalcaemia—Doxorubicin—sarcoma	0.000351	0.0059	CcSEcCtD
Alendronate—Photosensitivity reaction—Vincristine—sarcoma	0.000333	0.00559	CcSEcCtD
Alendronate—Haemoglobin—Thiotepa—sarcoma	0.000331	0.00555	CcSEcCtD
Alendronate—Haemorrhage—Thiotepa—sarcoma	0.000329	0.00552	CcSEcCtD
Alendronate—Stomatitis—Vincristine—sarcoma	0.000317	0.00532	CcSEcCtD
Alendronate—Erythema multiforme—Dactinomycin—sarcoma	0.000309	0.00518	CcSEcCtD
Alendronate—Stomatitis—Mitoxantrone—sarcoma	0.000309	0.00518	CcSEcCtD
Alendronate—Cramp muscle—Etoposide—sarcoma	0.000308	0.00516	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Etoposide—sarcoma	0.000308	0.00516	CcSEcCtD
Alendronate—Dysphagia—Etoposide—sarcoma	0.000295	0.00496	CcSEcCtD
Alendronate—Alopecia—Thiotepa—sarcoma	0.000291	0.00488	CcSEcCtD
Alendronate—Alopecia—Dactinomycin—sarcoma	0.000289	0.00484	CcSEcCtD
Alendronate—Hypocalcaemia—Epirubicin—sarcoma	0.000288	0.00484	CcSEcCtD
Alendronate—Erythema—Thiotepa—sarcoma	0.000287	0.00481	CcSEcCtD
Alendronate—Haemoglobin—Mitoxantrone—sarcoma	0.000286	0.00479	CcSEcCtD
Alendronate—Erythema—Dactinomycin—sarcoma	0.000284	0.00477	CcSEcCtD
Alendronate—Haemorrhage—Mitoxantrone—sarcoma	0.000284	0.00477	CcSEcCtD
Alendronate—Ulcer—Epirubicin—sarcoma	0.000279	0.00468	CcSEcCtD
Alendronate—Musculoskeletal pain—Epirubicin—sarcoma	0.000267	0.00448	CcSEcCtD
Alendronate—Hypocalcaemia—Doxorubicin—sarcoma	0.000267	0.00448	CcSEcCtD
Alendronate—Anaemia—Thiotepa—sarcoma	0.000265	0.00444	CcSEcCtD
Alendronate—Ill-defined disorder—Dactinomycin—sarcoma	0.000264	0.00443	CcSEcCtD
Alendronate—Anaemia—Dactinomycin—sarcoma	0.000263	0.00441	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000261	0.00438	CcSEcCtD
Alendronate—Ulcer—Doxorubicin—sarcoma	0.000258	0.00433	CcSEcCtD
Alendronate—Alopecia—Vincristine—sarcoma	0.000258	0.00433	CcSEcCtD
Alendronate—Melaena—Epirubicin—sarcoma	0.000258	0.00433	CcSEcCtD
Alendronate—Stomatitis—Etoposide—sarcoma	0.000257	0.00431	CcSEcCtD
Alendronate—Malaise—Dactinomycin—sarcoma	0.000256	0.0043	CcSEcCtD
Alendronate—Influenza like illness—Epirubicin—sarcoma	0.000256	0.0043	CcSEcCtD
Alendronate—Alopecia—Mitoxantrone—sarcoma	0.000251	0.00422	CcSEcCtD
Alendronate—Erythema—Mitoxantrone—sarcoma	0.000247	0.00415	CcSEcCtD
Alendronate—Musculoskeletal pain—Doxorubicin—sarcoma	0.000247	0.00415	CcSEcCtD
Alendronate—Myalgia—Thiotepa—sarcoma	0.000244	0.00409	CcSEcCtD
Alendronate—Dysgeusia—Mitoxantrone—sarcoma	0.000242	0.00407	CcSEcCtD
Alendronate—Myalgia—Dactinomycin—sarcoma	0.000242	0.00406	CcSEcCtD
Alendronate—Oesophagitis—Epirubicin—sarcoma	0.000241	0.00405	CcSEcCtD
Alendronate—Discomfort—Dactinomycin—sarcoma	0.000239	0.00401	CcSEcCtD
Alendronate—Melaena—Doxorubicin—sarcoma	0.000239	0.004	CcSEcCtD
Alendronate—Influenza like illness—Doxorubicin—sarcoma	0.000237	0.00398	CcSEcCtD
Alendronate—Anaemia—Vincristine—sarcoma	0.000235	0.00394	CcSEcCtD
Alendronate—Infection—Thiotepa—sarcoma	0.000232	0.0039	CcSEcCtD
Alendronate—Infection—Dactinomycin—sarcoma	0.000231	0.00387	CcSEcCtD
Alendronate—Ill-defined disorder—Mitoxantrone—sarcoma	0.00023	0.00385	CcSEcCtD
Alendronate—Anaemia—Mitoxantrone—sarcoma	0.000229	0.00384	CcSEcCtD
Alendronate—Vertigo—Vincristine—sarcoma	0.000228	0.00383	CcSEcCtD
Alendronate—Erythema multiforme—Etoposide—sarcoma	0.000224	0.00375	CcSEcCtD
Alendronate—Malaise—Mitoxantrone—sarcoma	0.000223	0.00374	CcSEcCtD
Alendronate—Oesophagitis—Doxorubicin—sarcoma	0.000223	0.00374	CcSEcCtD
Alendronate—Photosensitivity—Epirubicin—sarcoma	0.000218	0.00366	CcSEcCtD
Alendronate—Myalgia—Vincristine—sarcoma	0.000216	0.00363	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000213	0.00358	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000211	0.00355	CcSEcCtD
Alendronate—Chest pain—Mitoxantrone—sarcoma	0.000211	0.00354	CcSEcCtD
Alendronate—Myalgia—Mitoxantrone—sarcoma	0.000211	0.00354	CcSEcCtD
Alendronate—Alopecia—Etoposide—sarcoma	0.000209	0.00351	CcSEcCtD
Alendronate—Discomfort—Mitoxantrone—sarcoma	0.000208	0.00349	CcSEcCtD
Alendronate—Infection—Vincristine—sarcoma	0.000206	0.00346	CcSEcCtD
Alendronate—Dyspepsia—Thiotepa—sarcoma	0.000206	0.00345	CcSEcCtD
Alendronate—Photosensitivity—Doxorubicin—sarcoma	0.000202	0.00339	CcSEcCtD
Alendronate—Dysgeusia—Etoposide—sarcoma	0.000202	0.00338	CcSEcCtD
Alendronate—Infection—Mitoxantrone—sarcoma	0.000201	0.00337	CcSEcCtD
Alendronate—Pain—Thiotepa—sarcoma	0.0002	0.00336	CcSEcCtD
Alendronate—Constipation—Thiotepa—sarcoma	0.0002	0.00336	CcSEcCtD
Alendronate—Pain—Dactinomycin—sarcoma	0.000198	0.00333	CcSEcCtD
Alendronate—Muscle spasms—Etoposide—sarcoma	0.000198	0.00332	CcSEcCtD
Alendronate—Feeling abnormal—Thiotepa—sarcoma	0.000193	0.00323	CcSEcCtD
Alendronate—Feeling abnormal—Dactinomycin—sarcoma	0.000191	0.00321	CcSEcCtD
Alendronate—Gastrointestinal pain—Thiotepa—sarcoma	0.000191	0.00321	CcSEcCtD
Alendronate—Ill-defined disorder—Etoposide—sarcoma	0.000191	0.0032	CcSEcCtD
Alendronate—Anaemia—Etoposide—sarcoma	0.00019	0.00319	CcSEcCtD
Alendronate—Gastrointestinal pain—Dactinomycin—sarcoma	0.00019	0.00319	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Vincristine—sarcoma	0.000189	0.00317	CcSEcCtD
Alendronate—Urticaria—Thiotepa—sarcoma	0.000186	0.00312	CcSEcCtD
Alendronate—Malaise—Etoposide—sarcoma	0.000186	0.00311	CcSEcCtD
Alendronate—Vertigo—Etoposide—sarcoma	0.000185	0.0031	CcSEcCtD
Alendronate—Abdominal pain—Thiotepa—sarcoma	0.000185	0.0031	CcSEcCtD
Alendronate—Body temperature increased—Thiotepa—sarcoma	0.000185	0.0031	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000184	0.00309	CcSEcCtD
Alendronate—Body temperature increased—Dactinomycin—sarcoma	0.000183	0.00308	CcSEcCtD
Alendronate—Abdominal pain—Dactinomycin—sarcoma	0.000183	0.00308	CcSEcCtD
Alendronate—Dyspepsia—Mitoxantrone—sarcoma	0.000178	0.00298	CcSEcCtD
Alendronate—Constipation—Vincristine—sarcoma	0.000177	0.00298	CcSEcCtD
Alendronate—Pain—Vincristine—sarcoma	0.000177	0.00298	CcSEcCtD
Alendronate—Dry skin—Epirubicin—sarcoma	0.000176	0.00295	CcSEcCtD
Alendronate—Chest pain—Etoposide—sarcoma	0.000175	0.00294	CcSEcCtD
Alendronate—Discomfort—Etoposide—sarcoma	0.000173	0.00291	CcSEcCtD
Alendronate—Pain—Mitoxantrone—sarcoma	0.000173	0.0029	CcSEcCtD
Alendronate—Constipation—Mitoxantrone—sarcoma	0.000173	0.0029	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000172	0.0029	CcSEcCtD
Alendronate—Hypersensitivity—Thiotepa—sarcoma	0.000172	0.00289	CcSEcCtD
Alendronate—Hypersensitivity—Dactinomycin—sarcoma	0.000171	0.00287	CcSEcCtD
Alendronate—Gastrointestinal pain—Vincristine—sarcoma	0.00017	0.00285	CcSEcCtD
Alendronate—Gastritis—Epirubicin—sarcoma	0.00017	0.00285	CcSEcCtD
Alendronate—Asthenia—Thiotepa—sarcoma	0.000168	0.00282	CcSEcCtD
Alendronate—Infection—Etoposide—sarcoma	0.000167	0.0028	CcSEcCtD
Alendronate—Abdominal distension—Epirubicin—sarcoma	0.000167	0.0028	CcSEcCtD
Alendronate—Asthenia—Dactinomycin—sarcoma	0.000167	0.00279	CcSEcCtD
Alendronate—Feeling abnormal—Mitoxantrone—sarcoma	0.000166	0.00279	CcSEcCtD
Alendronate—Asthma—Epirubicin—sarcoma	0.000166	0.00278	CcSEcCtD
Alendronate—Dysphagia—Epirubicin—sarcoma	0.000166	0.00278	CcSEcCtD
Alendronate—Pruritus—Thiotepa—sarcoma	0.000165	0.00278	CcSEcCtD
Alendronate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000165	0.00277	CcSEcCtD
Alendronate—Abdominal pain—Vincristine—sarcoma	0.000164	0.00275	CcSEcCtD
Alendronate—Body temperature increased—Vincristine—sarcoma	0.000164	0.00275	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—sarcoma	0.000162	0.00273	CcSEcCtD
Alendronate—Urticaria—Mitoxantrone—sarcoma	0.00016	0.00269	CcSEcCtD
Alendronate—Diarrhoea—Thiotepa—sarcoma	0.00016	0.00269	CcSEcCtD
Alendronate—Abdominal pain—Mitoxantrone—sarcoma	0.00016	0.00268	CcSEcCtD
Alendronate—Body temperature increased—Mitoxantrone—sarcoma	0.00016	0.00268	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00016	0.00268	CcSEcCtD
Alendronate—Diarrhoea—Dactinomycin—sarcoma	0.000159	0.00267	CcSEcCtD
Alendronate—FDPS—SREBP signalling—CREB1—sarcoma	0.000158	0.0224	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—KDR—sarcoma	0.000158	0.0224	CbGpPWpGaD
Alendronate—Gastritis—Doxorubicin—sarcoma	0.000157	0.00263	CcSEcCtD
Alendronate—Dizziness—Thiotepa—sarcoma	0.000155	0.0026	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—sarcoma	0.000154	0.00259	CcSEcCtD
Alendronate—Asthma—Doxorubicin—sarcoma	0.000153	0.00257	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—sarcoma	0.000153	0.00257	CcSEcCtD
Alendronate—Hypersensitivity—Vincristine—sarcoma	0.000153	0.00256	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—sarcoma	0.000151	0.00254	CcSEcCtD
Alendronate—Hypersensitivity—Mitoxantrone—sarcoma	0.000149	0.0025	CcSEcCtD
Alendronate—Asthenia—Vincristine—sarcoma	0.000149	0.0025	CcSEcCtD
Alendronate—Vomiting—Thiotepa—sarcoma	0.000149	0.0025	CcSEcCtD
Alendronate—Vomiting—Dactinomycin—sarcoma	0.000148	0.00248	CcSEcCtD
Alendronate—Rash—Thiotepa—sarcoma	0.000147	0.00247	CcSEcCtD
Alendronate—Dermatitis—Thiotepa—sarcoma	0.000147	0.00247	CcSEcCtD
Alendronate—Headache—Thiotepa—sarcoma	0.000146	0.00246	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000146	0.00246	CcSEcCtD
Alendronate—Rash—Dactinomycin—sarcoma	0.000146	0.00246	CcSEcCtD
Alendronate—Asthenia—Mitoxantrone—sarcoma	0.000145	0.00243	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—sarcoma	0.000144	0.00242	CcSEcCtD
Alendronate—Constipation—Etoposide—sarcoma	0.000144	0.00241	CcSEcCtD
Alendronate—Pain—Etoposide—sarcoma	0.000144	0.00241	CcSEcCtD
Alendronate—Diarrhoea—Vincristine—sarcoma	0.000142	0.00238	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—sarcoma	0.00014	0.00235	CcSEcCtD
Alendronate—Nausea—Thiotepa—sarcoma	0.000139	0.00233	CcSEcCtD
Alendronate—Feeling abnormal—Etoposide—sarcoma	0.000138	0.00232	CcSEcCtD
Alendronate—Diarrhoea—Mitoxantrone—sarcoma	0.000138	0.00232	CcSEcCtD
Alendronate—Nausea—Dactinomycin—sarcoma	0.000138	0.00231	CcSEcCtD
Alendronate—Gastrointestinal pain—Etoposide—sarcoma	0.000137	0.00231	CcSEcCtD
Alendronate—Dizziness—Vincristine—sarcoma	0.000137	0.0023	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000135	0.00227	CcSEcCtD
Alendronate—Urticaria—Etoposide—sarcoma	0.000133	0.00224	CcSEcCtD
Alendronate—Haemoglobin—Epirubicin—sarcoma	0.000133	0.00224	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—sarcoma	0.000133	0.00223	CcSEcCtD
Alendronate—Abdominal pain—Etoposide—sarcoma	0.000133	0.00223	CcSEcCtD
Alendronate—Body temperature increased—Etoposide—sarcoma	0.000133	0.00223	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—sarcoma	0.000133	0.00222	CcSEcCtD
Alendronate—Vomiting—Vincristine—sarcoma	0.000132	0.00221	CcSEcCtD
Alendronate—Rash—Vincristine—sarcoma	0.000131	0.00219	CcSEcCtD
Alendronate—Dermatitis—Vincristine—sarcoma	0.000131	0.00219	CcSEcCtD
Alendronate—Oedema peripheral—Epirubicin—sarcoma	0.000131	0.00219	CcSEcCtD
Alendronate—Headache—Vincristine—sarcoma	0.00013	0.00218	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—sarcoma	0.000129	0.0183	CbGpPWpGaD
Alendronate—Vomiting—Mitoxantrone—sarcoma	0.000128	0.00215	CcSEcCtD
Alendronate—Rash—Mitoxantrone—sarcoma	0.000127	0.00214	CcSEcCtD
Alendronate—Dermatitis—Mitoxantrone—sarcoma	0.000127	0.00213	CcSEcCtD
Alendronate—Headache—Mitoxantrone—sarcoma	0.000127	0.00212	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—sarcoma	0.000125	0.0021	CcSEcCtD
Alendronate—Hypersensitivity—Etoposide—sarcoma	0.000124	0.00208	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—sarcoma	0.000123	0.00207	CcSEcCtD
Alendronate—Nausea—Vincristine—sarcoma	0.000123	0.00207	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—sarcoma	0.000123	0.00206	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—sarcoma	0.000121	0.00203	CcSEcCtD
Alendronate—Asthenia—Etoposide—sarcoma	0.000121	0.00202	CcSEcCtD
Alendronate—Nausea—Mitoxantrone—sarcoma	0.00012	0.00201	CcSEcCtD
Alendronate—Pruritus—Etoposide—sarcoma	0.000119	0.00199	CcSEcCtD
Alendronate—Alopecia—Epirubicin—sarcoma	0.000117	0.00197	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—sarcoma	0.000116	0.00195	CcSEcCtD
Alendronate—Erythema—Epirubicin—sarcoma	0.000115	0.00194	CcSEcCtD
Alendronate—Diarrhoea—Etoposide—sarcoma	0.000115	0.00193	CcSEcCtD
Alendronate—Flatulence—Epirubicin—sarcoma	0.000114	0.00191	CcSEcCtD
Alendronate—Dysgeusia—Epirubicin—sarcoma	0.000113	0.0019	CcSEcCtD
Alendronate—Dizziness—Etoposide—sarcoma	0.000111	0.00186	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—sarcoma	0.000111	0.00186	CcSEcCtD
Alendronate—Alopecia—Doxorubicin—sarcoma	0.000108	0.00182	CcSEcCtD
Alendronate—Ill-defined disorder—Epirubicin—sarcoma	0.000107	0.0018	CcSEcCtD
Alendronate—Vomiting—Etoposide—sarcoma	0.000107	0.00179	CcSEcCtD
Alendronate—Erythema—Doxorubicin—sarcoma	0.000107	0.00179	CcSEcCtD
Alendronate—Anaemia—Epirubicin—sarcoma	0.000107	0.00179	CcSEcCtD
Alendronate—Rash—Etoposide—sarcoma	0.000106	0.00178	CcSEcCtD
Alendronate—Dermatitis—Etoposide—sarcoma	0.000106	0.00178	CcSEcCtD
Alendronate—Headache—Etoposide—sarcoma	0.000105	0.00177	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—sarcoma	0.000105	0.00177	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—sarcoma	0.000105	0.00175	CcSEcCtD
Alendronate—Malaise—Epirubicin—sarcoma	0.000104	0.00175	CcSEcCtD
Alendronate—Vertigo—Epirubicin—sarcoma	0.000104	0.00174	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—sarcoma	0.000103	0.00172	CcSEcCtD
Alendronate—Nausea—Etoposide—sarcoma	9.98e-05	0.00167	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—sarcoma	9.9e-05	0.00166	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—sarcoma	9.87e-05	0.00166	CcSEcCtD
Alendronate—Chest pain—Epirubicin—sarcoma	9.82e-05	0.00165	CcSEcCtD
Alendronate—Myalgia—Epirubicin—sarcoma	9.82e-05	0.00165	CcSEcCtD
Alendronate—Discomfort—Epirubicin—sarcoma	9.7e-05	0.00163	CcSEcCtD
Alendronate—Malaise—Doxorubicin—sarcoma	9.63e-05	0.00162	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—sarcoma	9.59e-05	0.00161	CcSEcCtD
Alendronate—Infection—Epirubicin—sarcoma	9.35e-05	0.00157	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—sarcoma	9.09e-05	0.00153	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—sarcoma	9.09e-05	0.00153	CcSEcCtD
Alendronate—Discomfort—Doxorubicin—sarcoma	8.98e-05	0.00151	CcSEcCtD
Alendronate—Infection—Doxorubicin—sarcoma	8.65e-05	0.00145	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Epirubicin—sarcoma	8.58e-05	0.00144	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—sarcoma	8.29e-05	0.00139	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—NRAS—sarcoma	8.11e-05	0.0115	CbGpPWpGaD
Alendronate—Pain—Epirubicin—sarcoma	8.05e-05	0.00135	CcSEcCtD
Alendronate—Constipation—Epirubicin—sarcoma	8.05e-05	0.00135	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—sarcoma	7.94e-05	0.00133	CcSEcCtD
Alendronate—Feeling abnormal—Epirubicin—sarcoma	7.76e-05	0.0013	CcSEcCtD
Alendronate—Gastrointestinal pain—Epirubicin—sarcoma	7.7e-05	0.00129	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—sarcoma	7.67e-05	0.00129	CcSEcCtD
Alendronate—Urticaria—Epirubicin—sarcoma	7.48e-05	0.00126	CcSEcCtD
Alendronate—Pain—Doxorubicin—sarcoma	7.45e-05	0.00125	CcSEcCtD
Alendronate—Constipation—Doxorubicin—sarcoma	7.45e-05	0.00125	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—sarcoma	7.44e-05	0.00125	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—sarcoma	7.44e-05	0.00125	CcSEcCtD
Alendronate—Feeling abnormal—Doxorubicin—sarcoma	7.18e-05	0.0012	CcSEcCtD
Alendronate—Gastrointestinal pain—Doxorubicin—sarcoma	7.12e-05	0.0012	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KRAS—sarcoma	6.98e-05	0.00988	CbGpPWpGaD
Alendronate—Hypersensitivity—Epirubicin—sarcoma	6.94e-05	0.00116	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—sarcoma	6.92e-05	0.00116	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—sarcoma	6.89e-05	0.00116	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—sarcoma	6.89e-05	0.00116	CcSEcCtD
Alendronate—Asthenia—Epirubicin—sarcoma	6.76e-05	0.00113	CcSEcCtD
Alendronate—Pruritus—Epirubicin—sarcoma	6.66e-05	0.00112	CcSEcCtD
Alendronate—Diarrhoea—Epirubicin—sarcoma	6.44e-05	0.00108	CcSEcCtD
Alendronate—Hypersensitivity—Doxorubicin—sarcoma	6.42e-05	0.00108	CcSEcCtD
Alendronate—Asthenia—Doxorubicin—sarcoma	6.25e-05	0.00105	CcSEcCtD
Alendronate—Dizziness—Epirubicin—sarcoma	6.23e-05	0.00104	CcSEcCtD
Alendronate—Pruritus—Doxorubicin—sarcoma	6.16e-05	0.00103	CcSEcCtD
Alendronate—Vomiting—Epirubicin—sarcoma	5.99e-05	0.001	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—sarcoma	5.96e-05	0.001	CcSEcCtD
Alendronate—Rash—Epirubicin—sarcoma	5.94e-05	0.000996	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—HRAS—sarcoma	5.93e-05	0.0084	CbGpPWpGaD
Alendronate—Dermatitis—Epirubicin—sarcoma	5.93e-05	0.000995	CcSEcCtD
Alendronate—Headache—Epirubicin—sarcoma	5.9e-05	0.00099	CcSEcCtD
Alendronate—Dizziness—Doxorubicin—sarcoma	5.76e-05	0.000967	CcSEcCtD
Alendronate—ATP6V1A—Disease—TLE1—sarcoma	5.71e-05	0.00808	CbGpPWpGaD
Alendronate—Nausea—Epirubicin—sarcoma	5.59e-05	0.000939	CcSEcCtD
Alendronate—Vomiting—Doxorubicin—sarcoma	5.54e-05	0.00093	CcSEcCtD
Alendronate—Rash—Doxorubicin—sarcoma	5.49e-05	0.000922	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—sarcoma	5.49e-05	0.000921	CcSEcCtD
Alendronate—Headache—Doxorubicin—sarcoma	5.46e-05	0.000916	CcSEcCtD
Alendronate—Nausea—Doxorubicin—sarcoma	5.17e-05	0.000869	CcSEcCtD
Alendronate—ATP6V1A—Disease—NPM1—sarcoma	5.15e-05	0.00729	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ENO2—sarcoma	4.46e-05	0.00631	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TLE1—sarcoma	4e-05	0.00566	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PLCG1—sarcoma	3.78e-05	0.00536	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CXCR4—sarcoma	3.64e-05	0.00514	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFC—sarcoma	3.37e-05	0.00477	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ENO2—sarcoma	2.99e-05	0.00423	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HBA1—sarcoma	2.97e-05	0.0042	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FLT1—sarcoma	2.7e-05	0.00382	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FOXO1—sarcoma	2.68e-05	0.0038	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFRB—sarcoma	2.68e-05	0.00379	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PLCG1—sarcoma	2.65e-05	0.00375	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PDGFRA—sarcoma	2.64e-05	0.00373	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCR4—sarcoma	2.55e-05	0.0036	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLCG1—sarcoma	2.53e-05	0.00359	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ATF1—sarcoma	2.52e-05	0.00356	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KIT—sarcoma	2.05e-05	0.0029	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—sarcoma	1.98e-05	0.0028	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CREB1—sarcoma	1.95e-05	0.00276	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FOXO1—sarcoma	1.88e-05	0.00266	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFRB—sarcoma	1.88e-05	0.00266	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFRA—sarcoma	1.85e-05	0.00261	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MDM2—sarcoma	1.61e-05	0.00228	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—sarcoma	1.56e-05	0.0022	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KIT—sarcoma	1.43e-05	0.00203	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CTNNB1—sarcoma	1.39e-05	0.00197	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREB1—sarcoma	1.36e-05	0.00193	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—sarcoma	1.26e-05	0.00178	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NRAS—sarcoma	1.21e-05	0.00171	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MDM2—sarcoma	1.13e-05	0.0016	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—sarcoma	1.13e-05	0.00159	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—sarcoma	1.1e-05	0.00156	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—sarcoma	1.04e-05	0.00147	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL2—sarcoma	1.01e-05	0.00143	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—sarcoma	9.83e-06	0.00139	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JUN—sarcoma	9.81e-06	0.00139	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CTNNB1—sarcoma	9.73e-06	0.00138	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—sarcoma	8.84e-06	0.00125	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—sarcoma	8.8e-06	0.00124	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—sarcoma	8.57e-06	0.00121	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRAS—sarcoma	8.46e-06	0.0012	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—sarcoma	7.88e-06	0.00112	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—sarcoma	7.71e-06	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—sarcoma	7.28e-06	0.00103	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—sarcoma	6.47e-06	0.000916	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—sarcoma	6.19e-06	0.000876	CbGpPWpGaD
